Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 06, 2016 14:07 ET | Source: BioSyent Inc.

BioSyent to Present at Upcoming Investor Conferences

TORONTO, ONTARIO--(Marketwired - April 6, 2016) - BioSyent Inc. ("BioSyent")(TSX VENTURE:RX)(OTC PINK:BIOYF) is pleased to announce that it will be presenting at the following upcoming...
March 04, 2016 08:00 ET | Source: BioSyent Inc.

BioSyent Releases Q4 and Full Year 2015 Results

TORONTO, ONTARIO--(Marketwired - March 4, 2016) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX)(OTC PINK:BIOYF) released today a summary of its financial results for the three and twelve...
February 12, 2016 17:45 ET | Source: BioSyent Inc.

BioSyent Schedules Fourth Quarter 2015 Earnings Release for March 4, 2016

TORONTO, ONTARIO--(Marketwired - Feb. 12, 2016) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX)(OTC PINK:BIOYF) will be reporting its financial results for the fourth quarter and fiscal...
November 30, 2015 09:56 ET | Source: BioSyent Inc.

BioSyent to Present at the LD Micro Main Event 2015 Investor Conference

TORONTO, ONTARIO--(Marketwired - Nov. 30, 2015) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that CEO René Goehrum will be making a presentation at the LD...
November 17, 2015 08:00 ET | Source: BioSyent Inc.

BioSyent Pharma Announces the Canadian Launch of CYSVIEW(R) (Hexaminolevulinate Hydrochloride)

TORONTO, ONTARIO--(Marketwired - Nov. 17, 2015) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that its subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of...
November 11, 2015 08:00 ET | Source: BioSyent Inc.

BioSyent Releases Results for Third Quarter and First Nine Months of 2015

TORONTO, ONTARIO--(Marketwired - Nov. 11, 2015) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) released today a summary of its financial results for the three and nine months ending...
September 17, 2015 09:15 ET | Source: BioSyent Inc.

BioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies With a Five-Year Revenue Growth Rate of 1,086%

TORONTO, ONTARIO--(Marketwired - Sept. 17, 2015) - Editors Note: There is a photo associated with this press release. BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is...
August 19, 2015 08:00 ET | Source: BioSyent Inc.

BioSyent Pharma Acquires Exclusive Rights For Cysview(R) In Canada

TORONTO, ONTARIO--(Marketwired - Aug. 19, 2015) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) announced today that its subsidiary BioSyent Pharma Inc. has signed an agreement with...
August 12, 2015 08:00 ET | Source: BioSyent Inc.

BioSyent Releases First Six Months 2015 Results-Six Month Sales Up 25%; Pharma Sales Up 25%; EBITDA Up 31%; Net Income Up 30%; Return on Equity 40%

TORONTO, ONTARIO--(Marketwired - Aug. 12, 2015) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) released today a summary of its Second Quarter (Q2 2015) and first half financial results for...
May 13, 2015 16:21 ET | Source: BioSyent Inc.

CORRECTION FROM SOURCE: BioSyent Releases First Quarter 2015 Results - Sales Up 35%; Pharma Sales Up 38%; Ebitda up 92%; Diluted EPS $0.07, Up 75%; Net Income Up 88%

TORONTO, ONTARIO--(Marketwired - May 13, 2015) - A correction from source is being issued with respect to the BioSyent Inc. release that was disseminated May 13, 2015 at 08:00 ET. The...